Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortisone injection versus high-intensity laser therapy for rotator cuff tendinitis of the shoulder
IRCT20251114067994N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of prednisolone and lidocaine in rotator cuff tendinitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Shoulder pain. Started Dec 2025; status: completed.
02
Drugs
prednisolonelidocaine
03
Conditions
rotator cuff tendinitis
Beyond the preview
Go deeper on IRCT20251114067994N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251114067994N1.